As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screening-Reference-Cited by-同舟云学术

As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screening

Published:2018-04-25 Issue:6 Volume:143 Page:1287-1294
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Njor Sisse Helle¹²^ORCID,Paci Eugenio³,Rebolj Matejka⁴

Affiliation:

1. Department of Public Health ProgrammesRanders Regional HospitalRanders Denmark

2. Department of Clinical EpidemiologyAarhus UniversityAarhus Denmark

3. Former: ISPO Cancer Prevention and Research InstituteFlorence Italy

4. Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts & The London School of Medicine and Dentistry, Queen Mary University of LondonLondon United Kingdom

Funder

Cancer Research UK

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31420

Reference31 articles.

1. The benefits and harms of breast cancer screening: an independent review

2. The benefits and harms of breast cancer screening: an independent review

3. Breast Cancer Mortality in Mammographic Screening in Europe: A Review of Incidence-Based Mortality Studies

4. Systematic Review of the Side Effects Associated With Anti-HER2-Targeted Therapies Used in the Treatment of Breast Cancer, on Behalf of the EORTC Quality of Life Group

5. National Cancer Institute. Financial toxicity associated with cancer care ‐ background and prevalence. URL:https://www.cancer.gov/about-cancer/managing-care/track-care-costs/financial-toxicity-hp-pdq. Accessed August 11 2017.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics;Current Opinion in Oncology;2023-09-07

2. Do doctors and other healthcare professionals know overdiagnosis in screening and how are they dealing with it? A protocol for a mixed methods systematic review;BMJ Open;2022-10

3. Screening for cancer of the colon and rectum A review on incidence, mortality, cost and benefit;Læknablaðið;2021-09-03

4. Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?;BMJ Open;2021-06

5. Breast cancer screening and overdiagnosis;International Journal of Cancer;2021-05-03